Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a
G Antonelli, F Bagnato, C Pozzilli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
C Gasperini, C Pozzilli, S Bastianello, et al.
Journal of Neurology
|
November 7, 1999
Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images
M Rovaris, F Barkhof, S Bastianello, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 17, 1999
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
M Filippi, M Rovaris, R Capra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1996
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis
C Pozzilli, S Bastianello, T Koudriavtseva, et al.
Journal of Neurovirology
|
June 29, 2000
MRI of spinal cord in MS
S Bastianello, A Paolillo, E Giugni, et al.
Acta Neurologica Scandinavica
|
April 1, 1997
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients
C Gasperini, C Pozzilli, S Bastianello, et al.
Lancet (London, England)
|
August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group
L Kappos, D Moeri, E W Radue, et al.
Journal of Neuroimmunology
|
June 16, 2000
Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens
G Borsellino, O Koul, R Placido, et al.
Annals of Neurology
|
March 20, 1998
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis
P D Molyneux, M Filippi, F Barkhof, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a
G Antonelli, F Bagnato, C Pozzilli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
C Gasperini, C Pozzilli, S Bastianello, et al.
Journal of Neurology
|
November 7, 1999
Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images
M Rovaris, F Barkhof, S Bastianello, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 17, 1999
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
M Filippi, M Rovaris, R Capra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1996
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis
C Pozzilli, S Bastianello, T Koudriavtseva, et al.
Journal of Neurovirology
|
June 29, 2000
MRI of spinal cord in MS
S Bastianello, A Paolillo, E Giugni, et al.
Acta Neurologica Scandinavica
|
April 1, 1997
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients
C Gasperini, C Pozzilli, S Bastianello, et al.
Lancet (London, England)
|
August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group
L Kappos, D Moeri, E W Radue, et al.
Journal of Neuroimmunology
|
June 16, 2000
Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens
G Borsellino, O Koul, R Placido, et al.
Annals of Neurology
|
March 20, 1998
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis
P D Molyneux, M Filippi, F Barkhof, et al.
Page
of 10